News

A CRISPR treatment seems to have been effective for a baby’s devastating disease, but it is not clear whether such bespoke ...
A cell's primary cilia function like antennae. Operating like a 24/7 news outlet, these hairlike structures are present on the surface of all animal cells, where they receive signals or information ...
ADAM19 appears to play a significant role in reducing the inflammatory response associated with intestinal damage and ...
Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...
Japan has made regenerative medicine a priority. It was the first country to approve clinical use of iPS cells, and it ...
Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it. After treatment with CAR-T ...
The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.
When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to ...
American depository receipts of Immutep rose after the company reported positive results from a trial of its combination treatment for non-small cell lung cancer. Immutep climbed 16% to $2.11 on ...